These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24279428)

  • 1. Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury.
    Yan EB; Satgunaseelan L; Paul E; Bye N; Nguyen P; Agyapomaa D; Kossmann T; Rosenfeld JV; Morganti-Kossmann MC
    J Neurotrauma; 2014 Apr; 31(7):618-29. PubMed ID: 24279428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactic acid, neuron-specific enolase, and blood-brain barrier index after a severe traumatic brain injury: a prospective study.
    Lu W; Jiang C; Wang Z; Chen Y; Bai R; Yan G; Wang G; Ren H
    Br J Neurosurg; 2024 Apr; 38(2):220-224. PubMed ID: 33016150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.
    Hayakata T; Shiozaki T; Tasaki O; Ikegawa H; Inoue Y; Toshiyuki F; Hosotubo H; Kieko F; Yamashita T; Tanaka H; Shimazu T; Sugimoto H
    Shock; 2004 Aug; 22(2):102-7. PubMed ID: 15257081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury.
    Nwachuku EL; Puccio AM; Adeboye A; Chang YF; Kim J; Okonkwo DO
    Clin Neurol Neurosurg; 2016 Oct; 149():1-5. PubMed ID: 27450760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel Cerebrospinal Fluid and Serum Temporal Profile Assessment of Axonal Injury Biomarkers Neurofilament-Light Chain and Phosphorylated Neurofilament-Heavy Chain: Associations With Patient Outcome in Moderate-Severe Traumatic Brain Injury.
    Wang KKW; Barton DJ; McQuillan LE; Kobeissy F; Cai G; Xu H; Yang Z; Trifilio E; Williamson JB; Rubenstein R; Robertson CS; Wagner AK
    J Neurotrauma; 2024 Jul; 41(13-14):1609-1627. PubMed ID: 38588256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury.
    Santarsieri M; Niyonkuru C; McCullough EH; Dobos JA; Dixon CE; Berga SL; Wagner AK
    J Neurotrauma; 2014 Apr; 31(8):699-712. PubMed ID: 24354775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.
    Blyth BJ; Farhavar A; Gee C; Hawthorn B; He H; Nayak A; Stöcklein V; Bazarian JJ
    J Neurotrauma; 2009 Sep; 26(9):1497-1507. PubMed ID: 19257803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function.
    Morganti-Kossmann MC; Hans VH; Lenzlinger PM; Dubs R; Ludwig E; Trentz O; Kossmann T
    J Neurotrauma; 1999 Jul; 16(7):617-28. PubMed ID: 10447073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study.
    Lindblad C; Pin E; Just D; Al Nimer F; Nilsson P; Bellander BM; Svensson M; Piehl F; Thelin EP
    Crit Care; 2021 Mar; 25(1):103. PubMed ID: 33712077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury.
    Di Battista AP; Rhind SG; Hutchison MG; Hassan S; Shiu MY; Inaba K; Topolovec-Vranic J; Neto AC; Rizoli SB; Baker AJ
    J Neuroinflammation; 2016 Feb; 13():40. PubMed ID: 26883121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome.
    Kumar RG; Diamond ML; Boles JA; Berger RP; Tisherman SA; Kochanek PM; Wagner AK
    Brain Behav Immun; 2015 Mar; 45():253-62. PubMed ID: 25555531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
    Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Clark RS; Ruppel RA; Kochanek PM
    Pediatrics; 2002 Feb; 109(2):E31. PubMed ID: 11826241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.
    Csuka E; Morganti-Kossmann MC; Lenzlinger PM; Joller H; Trentz O; Kossmann T
    J Neuroimmunol; 1999 Nov; 101(2):211-21. PubMed ID: 10580806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury.
    Blyth BJ; Farahvar A; He H; Nayak A; Yang C; Shaw G; Bazarian JJ
    J Neurotrauma; 2011 Dec; 28(12):2453-62. PubMed ID: 21428722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury.
    Shore PM; Berger RP; Varma S; Janesko KL; Wisniewski SR; Clark RS; Adelson PD; Thomas NJ; Lai YC; Bayir H; Kochanek PM
    J Neurotrauma; 2007 Jan; 24(1):75-86. PubMed ID: 17263671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CSF biomarkers and secondary insults following severe traumatic brain injury.
    Stein DM; Kufera JA; Lindell A; Murdock KR; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
    Neurocrit Care; 2011 Apr; 14(2):200-7. PubMed ID: 21210304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury.
    Berger RP; Bazaco MC; Wagner AK; Kochanek PM; Fabio A
    Dev Neurosci; 2010; 32(5-6):396-405. PubMed ID: 20847541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMPACT probability of poor outcome and plasma cytokine concentrations are associated with multiple organ dysfunction syndrome following traumatic brain injury.
    Lee S; Hwang H; Yamal JM; Goodman JC; Aisiku IP; Gopinath S; Robertson CS
    J Neurosurg; 2019 Dec; 131(6):1931-1937. PubMed ID: 30641838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 mediates neuroinflammation and motor coordination deficits after mild traumatic brain injury and brief hypoxia in mice.
    Yang SH; Gangidine M; Pritts TA; Goodman MD; Lentsch AB
    Shock; 2013 Dec; 40(6):471-5. PubMed ID: 24088994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.